Latest filing published 03 Jan 2019 for NYMOX PHARMACEUTICAL CORP, €6,769.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Erik Danielsen: trading record in brief
All filings by Erik Danielsen on record concern Nymox Pharmaceutical Corp. Between 19 December 2018 and 21 December 2018, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €14k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2019, the count stands at 2 purchases and no sales.
Most recently, on 3 January 2019, the filings show an open-market purchase worth €6,769 in Nymox Pharmaceutical Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Erik Danielsen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$1.54Common StockSEC:0001682873-19-000001:0Canonical exit: 19 Mar 2019 (T+90)
- 6,000 shares@ US$1.35common stockSEC:0001682873-19-000002:0Canonical exit: 21 Mar 2019 (T+90)
2 of 2 declarations